Serial Number
98043024
Owner
Cantex Pharmaceuticals, Inc.Attorney
Michael J. BelliveauFirst Use Date
Apr 28, 2023
Filing Date
Jun 14, 2023
CANTEX Trademark
Serial Number: 98043024
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Michael J. Belliveau Clark+Elbing LLP
One Financial Center, Suite 2110
Boston, MA 02111
United States
Trademark Details
Filing Date
June 14, 2023
Registration Date
Not Registered
First Use Anywhere
April 28, 2023
First Use in Commerce
April 28, 2023
Published for Opposition
March 4, 2025
Goods & Services
Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for inhibiting Receptor for Advanced Glycation End products (RAGE) interactions, for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Pharmaceutical preparations for use in personalized medicine and targeted therapy in the field of Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases
